128 related articles for article (PubMed ID: 12559647)
1. Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial.
Gilpin AM; Holbrook JT; Jabs DA; Meinert CL;
Control Clin Trials; 2003 Feb; 24(1):92-8. PubMed ID: 12559647
[TBL] [Abstract][Full Text] [Related]
2. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group. AIDS Clinical Trials Group.
Arch Ophthalmol; 1997 Dec; 115(12):1528-36. PubMed ID: 9400786
[TBL] [Abstract][Full Text] [Related]
3. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
Borucki MJ; Spritzler J; Asmuth DM; Gnann J; Hirsch MS; Nokta M; Aweeka F; Nadler PI; Sattler F; Alston B; Nevin TT; Owens S; Waterman K; Hubbard L; Caliendo A; Pollard RB;
Antiviral Res; 2004 Nov; 64(2):103-11. PubMed ID: 15498605
[TBL] [Abstract][Full Text] [Related]
4. CMV retinitis monoclonal antibody trial halted.
McCarthy M
Lancet; 1996 Aug; 348(9027):603. PubMed ID: 8774578
[No Abstract] [Full Text] [Related]
5. DSMB case study: decision making when a similar clinical trial is stopped early.
Hillman DW; Louis TA
Control Clin Trials; 2003 Feb; 24(1):85-91. PubMed ID: 12559646
[TBL] [Abstract][Full Text] [Related]
6. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.
Jabs DA; Gilpin AM; Min YI; Erice A; Kempen JH; Quinn TC;
AIDS; 2002 Apr; 16(6):877-87. PubMed ID: 11919489
[TBL] [Abstract][Full Text] [Related]
7. Data and safety monitoring board issues raised in the VA Status Epilepticus Study.
Collins JF
Control Clin Trials; 2003 Feb; 24(1):71-7. PubMed ID: 12559644
[TBL] [Abstract][Full Text] [Related]
8. Stopping the active intervention: CARET.
Bowen DJ; Thornquist M; Anderson K; Barnett M; Powell C; Goodman G; Omenn G;
Control Clin Trials; 2003 Feb; 24(1):39-50. PubMed ID: 12559641
[TBL] [Abstract][Full Text] [Related]
9. The independent statistician model: How well is it working?
DeMets D
Clin Trials; 2018 Aug; 15(4):329-334. PubMed ID: 29741390
[TBL] [Abstract][Full Text] [Related]
10. A model for the interim analysis process: a case study.
Delgado-Herrera L; Anbar D
Control Clin Trials; 2003 Feb; 24(1):51-65. PubMed ID: 12559642
[TBL] [Abstract][Full Text] [Related]
11. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
12. Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implications.
Scheifele D; Duval B; De Serres G; Skowronski DM
Control Clin Trials; 2003 Feb; 24(1):99-104. PubMed ID: 12559648
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
[TBL] [Abstract][Full Text] [Related]
14. The management of cytomegalovirus retinitis in AIDS.
Dhillon B
Br J Ophthalmol; 1994 Jan; 78(1):66-9. PubMed ID: 8110704
[No Abstract] [Full Text] [Related]
15. Termination of a randomized controlled trial of two vasectomy techniques.
Chen-Mok M; Bangdiwala SI; Dominik R; Hays M; Irsula B; Sokal DC
Control Clin Trials; 2003 Feb; 24(1):78-84. PubMed ID: 12559645
[TBL] [Abstract][Full Text] [Related]
16. An algorithmic approach to treatment of cytomegalovirus retinitis.
Davis JL
Semin Ophthalmol; 1995 Jun; 10(2):119-24. PubMed ID: 10155625
[No Abstract] [Full Text] [Related]
17. Data and safety monitoring during randomized controlled trials of nursing interventions.
Artinian NT; Froelicher ES; Vander Wal JS
Nurs Res; 2004; 53(6):414-8. PubMed ID: 15586138
[TBL] [Abstract][Full Text] [Related]
18. The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials.
DeMets DL; Fleming TR; Whitley RJ; Childress JF; Ellenberg SS; Foulkes M; Mayer KH; O'Fallon J; Pollard RB; Rahal JJ
Control Clin Trials; 1995 Dec; 16(6):408-21. PubMed ID: 8720018
[TBL] [Abstract][Full Text] [Related]
19. [Retinitis due to cytomegalovirus in AIDS].
Mackiewicz J; Stransky TJ
Klin Oczna; 1995; 97(3-4):74-6. PubMed ID: 7474799
[TBL] [Abstract][Full Text] [Related]
20. Acquiring skills in management of HIV-related and other newer infections of the eye.
Jalali S
Indian J Ophthalmol; 2002 Jun; 50(2):80-1. PubMed ID: 12194583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
